Understanding vaccine vectors for HIV and CMV

Admin Core

NIH-funded research Oregon Health & Science University · NIH-10895451

This study is working on a new way to help scientists develop better vaccines for HIV and CMV, which could lead to improved treatments for patients like you.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionOregon Health & Science University NIH-funded
Lab location1 site (Portland, United States)
Project IDNIH-10895451 on NIH RePORTER

What this research studies

This research focuses on creating an effective organizational framework to support a multi-project program aimed at developing vaccine vectors for HIV and CMV. It involves evaluating the replication arrest efficacy of specific vaccine vectors and facilitating collaboration among scientists. The core provides essential administrative support, including data management, regulatory compliance, and progress evaluation, to ensure the program's success. Patients may benefit from advancements in vaccine development that could lead to improved treatments for HIV and related conditions.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit are individuals at risk for or living with HIV or CMV infections.

Not a fit: Patients who are not affected by HIV or CMV may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective vaccines for HIV and CMV, improving patient outcomes.

How similar studies have performed: Other research has shown promise in developing vaccine vectors for similar viruses, indicating potential for success in this approach.

Where this research is happening

Portland, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.